12
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Doppler ultrasound measurements of knee joint synovitis in rheumatoid arthritis patients treated with infliximab

, , , , , & show all
Pages 376-379 | Received 19 Mar 2007, Accepted 10 May 2007, Published online: 02 Jan 2014

References

  • Hau M, Kneitz C, Tony H-P, Keberle M, Jahns R, Jenett M, et al. High resolution ultrasound detects a decrease in pannus vascular-ization of small finger joints in patients with rheumatoid arthritis receiving with soluble tumor necrosis factor a receptor (etaner-cept). Ann Rheum Dis 2002;61:55–8.
  • Ftibbens C, Andre B, Marcelis S, Kaye 0, Mathy L, Bonnet V, et al. Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor a treat-ment: pilot study. Radiology 2003;229: 562–9.
  • Terslev L, Torp-Pedersen S, Qvistgaard E, Kristofferssen H, Rogind H. Effect of treatment with etanercept (Enbrel,TNFtF: Fc) on rheumatoid arthritis evaluated by Doppler ultrasonography. Ann Rheum Dis 2003;62:178–81.
  • Taylor PC, Steuer A, Gruber J, Cosgrove DO, Blomley MJK, Marsters PA, et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum 2004;50:1107–16.
  • Fiocco U, Ferro F, Vezzu M, Cozzi L, Checchetto C, Sfriso P, et al. Rheumatoid and psoriatic knee synovitis: clinical, gray-scale and power Doppler ultrasound assessment of the response to etan-ercept. Ann Rheum Dis 2005;64:899–905.
  • Kanno Y, Homma F, Takahashi A, Sato A, Yamadera Y, Ohguchi Y, et al. Doppler sonographic evaluation of infliximab therapy for rheumatoid arthritis. Mod Ftheumatol 2005;15:305–6.
  • Shio K, Homma F, Kanno Y, Yamadera Y, Ohguchi Y, Nishimaki T, et al. Doppler sonographic comparative study on usefulness of synovial vascularity between knee and metacarpophalangeal joints for evaluation of articular inflammation in patients with rheuma-toid arthritis treated by infliximab. Mod Ftheumatol 2006;16: 220–5.
  • Filippucci E, Iagnocco A, Salaffi F, Cerioni A, Valesini G, Grassi W. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Ann Rheum Dis 2006;65:1433–7.
  • Kasukawa R, Shio K, Kanno Y, Sato A, Takahashi A, Yamadera Y, et al. Power Doppler and spectral Doppler measurements of knee joint synovitis in rheumatoid arthritis patients with superficial pattern signals and in those with deep pattern signals. Mod Ftheu-matol 2007;17:267–72.
  • Arnett FC, Edworthy SM, Block DA, McShane DJ, Fries FJ, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthri-tis Rheum 1988;31:315–24.
  • Miyasaka N, Takeuchi T, Eguchi K. Official Japanese guideline for the use of infliximab for rheumatoid arthritis. Mod Ftheumatol 2005;15:4–8.
  • Kasukawa R, Yamadera Y, Takahashi A, Takeda I, Kanno T. Power Doppler sonography of intraarticular vascularization in knee joints of patients with rheumatoid arthritis. Mod Ftheumatol 2004;14:149–53.
  • Kasukawa R, Shio K, Kanno Y, Sato A, Takahashi A, Yamadera Y, et al. Doppler ultrasonographic characteristics of superficial and deep-flow signals in the knee joint pannus of rheumatoid arthritis patients. Ann Rheum Dis 2007;66:707–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.